
Mark L. Berch
Examiner (ID: 5665)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 1622, 1202, 2899, 1614, 1802, 1611, 1624 |
| Total Applications | 3573 |
| Issued Applications | 2301 |
| Pending Applications | 170 |
| Abandoned Applications | 1103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7128076
[patent_doc_number] => 20050059820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Method for manufacture of ceftriaxone sodium'
[patent_app_type] => utility
[patent_app_number] => 10/671298
[patent_app_country] => US
[patent_app_date] => 2003-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14936
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10671298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/671298 | Method for manufacture of ceftriaxone sodium | Sep 24, 2003 | Abandoned |
Array
(
[id] => 7455466
[patent_doc_number] => 20040068111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Unsaturated phosphonate derivatives of purines and pyrimidines'
[patent_app_type] => new
[patent_app_number] => 10/663414
[patent_app_country] => US
[patent_app_date] => 2003-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9109
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20040068111.pdf
[firstpage_image] =>[orig_patent_app_number] => 10663414
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/663414 | Unsaturated phosphonate derivatives of purines and pyrimidines | Sep 15, 2003 | Abandoned |
Array
(
[id] => 7209116
[patent_doc_number] => 20040087787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Novel thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds'
[patent_app_type] => new
[patent_app_number] => 10/250655
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4402
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087787.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250655
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250655 | Novel thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds | Sep 11, 2003 | Abandoned |
Array
(
[id] => 7128074
[patent_doc_number] => 20050059818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Polymorph of a pharmaceutical'
[patent_app_type] => utility
[patent_app_number] => 10/661148
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5860
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10661148
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/661148 | Polymorph of a pharmaceutical | Sep 11, 2003 | Abandoned |
Array
(
[id] => 7336976
[patent_doc_number] => 20040132707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Catecholate beta-lactam conjugates, method for producing the same and the use thereof'
[patent_app_type] => new
[patent_app_number] => 10/651251
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7903
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132707.pdf
[firstpage_image] =>[orig_patent_app_number] => 10651251
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/651251 | Catecholate beta-lactam conjugates, method for producing the same and the use thereof | Aug 28, 2003 | Abandoned |
Array
(
[id] => 7474787
[patent_doc_number] => 20040097528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Crystalline solid famciclovir forms I, II, III and preparation thereof'
[patent_app_type] => new
[patent_app_number] => 10/649399
[patent_app_country] => US
[patent_app_date] => 2003-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4854
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097528.pdf
[firstpage_image] =>[orig_patent_app_number] => 10649399
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/649399 | Crystalline solid famciclovir forms I, II, III and preparation thereof | Aug 25, 2003 | Abandoned |
Array
(
[id] => 6978785
[patent_doc_number] => 20050288503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Novel compounds'
[patent_app_type] => utility
[patent_app_number] => 10/525478
[patent_app_country] => US
[patent_app_date] => 2003-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18774
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20050288503.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525478
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525478 | Novel compounds | Aug 25, 2003 | Abandoned |
Array
(
[id] => 7290999
[patent_doc_number] => 20040110740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Beta-lactamase inhibitor prodrug'
[patent_app_type] => new
[patent_app_number] => 10/648408
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15340
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110740.pdf
[firstpage_image] =>[orig_patent_app_number] => 10648408
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/648408 | Beta-lactamase inhibitor prodrug | Aug 24, 2003 | Issued |
Array
(
[id] => 7355520
[patent_doc_number] => 20040048865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Antagonists of chemokine receptors'
[patent_app_type] => new
[patent_app_number] => 10/648677
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12583
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048865.pdf
[firstpage_image] =>[orig_patent_app_number] => 10648677
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/648677 | Antagonists of chemokine receptors | Aug 24, 2003 | Issued |
Array
(
[id] => 7238260
[patent_doc_number] => 20050080090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Naphthalene derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/645121
[patent_app_country] => US
[patent_app_date] => 2003-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32150
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080090.pdf
[firstpage_image] =>[orig_patent_app_number] => 10645121
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/645121 | Naphthalene derivatives | Aug 20, 2003 | Abandoned |
Array
(
[id] => 7453764
[patent_doc_number] => 20040067966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Adenosine receptor antagonists and methods of making and using the same'
[patent_app_type] => new
[patent_app_number] => 10/646454
[patent_app_country] => US
[patent_app_date] => 2003-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 36275
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067966.pdf
[firstpage_image] =>[orig_patent_app_number] => 10646454
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/646454 | Adenosine receptor antagonists and methods of making and using the same | Aug 20, 2003 | Abandoned |
Array
(
[id] => 7281350
[patent_doc_number] => 20040063727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => '6-Substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents'
[patent_app_type] => new
[patent_app_number] => 10/640154
[patent_app_country] => US
[patent_app_date] => 2003-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31596
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063727.pdf
[firstpage_image] =>[orig_patent_app_number] => 10640154
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/640154 | 6-Substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents | Aug 12, 2003 | Abandoned |
Array
(
[id] => 7474607
[patent_doc_number] => 20040097510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => '8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions'
[patent_app_type] => new
[patent_app_number] => 10/639036
[patent_app_country] => US
[patent_app_date] => 2003-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53024
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097510.pdf
[firstpage_image] =>[orig_patent_app_number] => 10639036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/639036 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | Aug 11, 2003 | Issued |
Array
(
[id] => 5821273
[patent_doc_number] => 20060025586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Cefdinir intermediate'
[patent_app_type] => utility
[patent_app_number] => 10/524397
[patent_app_country] => US
[patent_app_date] => 2003-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 4999
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20060025586.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524397
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524397 | Cefdinir intermediate | Aug 11, 2003 | Issued |
Array
(
[id] => 5041228
[patent_doc_number] => 20070093510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Phosphodiesterase 4 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/636979
[patent_app_country] => US
[patent_app_date] => 2003-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26008
[patent_no_of_claims] => 95
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20070093510.pdf
[firstpage_image] =>[orig_patent_app_number] => 10636979
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/636979 | Phosphodiesterase 4 inhibitors | Aug 7, 2003 | Issued |
Array
(
[id] => 7469644
[patent_doc_number] => 20040102460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Phosphodiesterase 4 inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/636996
[patent_app_country] => US
[patent_app_date] => 2003-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19753
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102460.pdf
[firstpage_image] =>[orig_patent_app_number] => 10636996
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/636996 | Phosphodiesterase 4 inhibitors | Aug 7, 2003 | Issued |
Array
(
[id] => 348889
[patent_doc_number] => 07495005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-24
[patent_title] => 'Xanthine derivatives, their preparation and their use in pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/636088
[patent_app_country] => US
[patent_app_date] => 2003-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11508
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/495/07495005.pdf
[firstpage_image] =>[orig_patent_app_number] => 10636088
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/636088 | Xanthine derivatives, their preparation and their use in pharmaceutical compositions | Aug 6, 2003 | Issued |
Array
(
[id] => 7475138
[patent_doc_number] => 20040122228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'New purine derivatives, the preparation thereof and their use as pharmaceutical compositions'
[patent_app_type] => new
[patent_app_number] => 10/634047
[patent_app_country] => US
[patent_app_date] => 2003-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23859
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20040122228.pdf
[firstpage_image] =>[orig_patent_app_number] => 10634047
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/634047 | Purine derivatives, the preparation thereof and their use as pharmaceutical compositions | Aug 3, 2003 | Issued |
Array
(
[id] => 990928
[patent_doc_number] => 06919455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-19
[patent_title] => 'Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof'
[patent_app_type] => utility
[patent_app_number] => 10/631795
[patent_app_country] => US
[patent_app_date] => 2003-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5675
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919455.pdf
[firstpage_image] =>[orig_patent_app_number] => 10631795
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/631795 | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof | Jul 31, 2003 | Issued |
Array
(
[id] => 7386828
[patent_doc_number] => 20040029835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Camptothecin analogs and methods of preparation thereof'
[patent_app_type] => new
[patent_app_number] => 10/629432
[patent_app_country] => US
[patent_app_date] => 2003-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16685
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029835.pdf
[firstpage_image] =>[orig_patent_app_number] => 10629432
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/629432 | Camptothecin analogs and methods of preparation thereof | Jul 28, 2003 | Issued |